Or Eisenberg

Wize Pharma Ltd. engages in purchase, marketing, sale, and distribution of drug for treatment of dry eye and other ophthalmologic diseases. The company was founded on June 23, 1982 and is headquartered in Hod HaSharon, Israel.

Part of Ernst & Young Global Ltd., Kost Forer Gabbay & Kasierer is an Israeli company that offers audit, FAAS, and forensic & integrity services to address risk and identify opportunities to enhance trust in the capital markets. The private company is based in Tel Aviv, Israel. The company also has EY-Parthenon teams that help CEOs create long-term value from strategy to execution. Additionally, Kost Forer Gabbay & Kasierer's analytics consulting services utilize the latest technology to integrate data and analytics throughout business processes and operations.

Katzir Fund Debenture for Investment Ltd. operates investment funds. The private company is based in Tel Aviv, Israel. The Israeli company was founded by Rami Mandola. Rami Mandola has been the CEO since incorporation.

Ernst & Young Global Ltd. engages in the provision consulting services. Its services include assurance, consulting, strategy and transaction, and tax. The company was founded on November 26, 2001 and is headquartered in London, the United Kingdom.

Wize Pharma, Inc. develops, produces and sells electronic and electro-optical systems. It focuses on treatment of ophthalmic disorders including Dry Eye Syndrome and other inflammatory conditions. The company holds rights to purchase, market, sell, and distribute LO2A. The company was founded on December 10, 1999 and is headquartered in Hod Ha'Sharon, Israel.